Regulatory agencies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) play a vital role in monitoring and managing adverse reactions. These agencies require comprehensive data on adverse reactions from clinical trials before approving any medical intervention. They also mandate post-marketing surveillance and may issue warnings, restrictions, or recalls based on the findings. Publicly accessible databases maintained by these agencies allow for transparency in reporting and investigating adverse reactions.
